1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > In Vitro Diagnostics Analysis & Statistics

In Vitro Diagnostics Analysis & Statistics

1-30 of 68 reports

Continuous Glucose Monitors - Medical Devices Pipeline Assessment, 2020

  • $ 4000
  • September 2020
  • 224 pages

Continuous Glucose Monitors - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Continuous Glucose Monitors - Medical Devices Pipeline Assessment, 2020" provides comprehensive ...

  • Clinical Trial
  • Diabetes Monitoring
  • In Vitro Diagnostics
  • United States
  • Medtronic, Inc.

Chromatography Accessories & Consumables Market by Product, Technology, End-user -Global Forecasts to 2025

  • $ 4950
  • August 2020
  • 245 pages

The chromatography accessories and consumables market is projected to grow at a CAGR of 5.0%. The global chromatography accessories and consumables market is projected to reach USD 4.6 billion by 2025 ...

  • In Vitro Diagnostics
  • North America
  • United States
  • Demand
  • Market Size

2020 Global Microbiology Market: Instrumentation and Supplier Profiles

  • $ 2450
  • August 2020
  • 86 pages

2020 Global Microbiology Market: Instrumentation and Supplier Profiles--Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, Immunodiagnostics--Infectious ...

  • Diagnostics
  • In Vitro Diagnostics
  • Medical Biotechnology
  • World

North America Microfluidics Market Forecast to 2027 – COVID-19 Impact and Country Analysis – by Product, Material, Application ; and Country

  • $ 3000
  • August 2020
  • 126 pages

The North America microfluidics market was valued at US$ 4,901.47 million in 2019 and is projected to reach US$ 18,301.24 million by 2027; it is expected to grow at a CAGR of 18.2% during 2020–2027. The ...

  • In Vitro Diagnostics
  • North America
  • United States
  • Forecast
  • Agilent Technologies, Inc.

Europe Microfluidics Market Forecast to 2027 – COVID-19 Impact and Country Analysis – by Product, Material, Application ; and Country

  • $ 3000
  • August 2020
  • 142 pages

The Europe microfluidics market was valued at US$ 3,625.15 million in 2019 and is projected to reach US$ 12,827.36 million by 2027; it is expected to grow at a CAGR of 17.4% during 2020–2027. The growth ...

  • In Vitro Diagnostics
  • Europe
  • World
  • Forecast
  • Thermo Fisher Scientific, Inc.

Asia Pacific Microtome Market to 2027 – Country Analysis and Forecasts by Product ; Technology ; End User

  • $ 3000
  • August 2020
  • 134 pages

Asia Pacific Microtome Market is expected to reach US$ 40,160.6 thousand in 2027 from US$ 24,937.2 thousand in 2019. The market is expected to grow with a CAGR of 6.3% from 2020-2027. The growth of the ...

  • In Vitro Diagnostics
  • APAC
  • East Asia
  • Forecast
  • Agilent Technologies, Inc.

Anatomic Pathology Market by Product, Application ), End User, Region - Global Forecasts to 2025

  • $ 4950
  • August 2020
  • 289 pages

Anatomic pathology market to register a CAGR of 7.1% from 2020 to 2025. The global anatomic pathology market size is projected to reach a value of USD 46.8 billion by 2025 from USD 33.3 billion in 2020, ...

  • Hospital
  • In Vitro Diagnostics
  • North America
  • United States
  • Market Size

Immunohistochemistry Market by Product, Application, Research, Forensic), End User - Global Forecast to 2025

  • $ 4950
  • August 2020
  • 226 pages

Increasing incidence of chronic diseases, and technological advancements in IHC are set to drive the IHC market.’’ The global immunohistochemistry market is projected to reach USD 2.7 billion by 2025 ...

  • In Vitro Diagnostics
  • Laboratory
  • North America
  • United States
  • Roche Group

Troponin Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020

  • $ 2500
  • August 2020
  • 40 pages

Troponin Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Troponin Rapid Tests and Point of Care (POC) - Medical Devices Pipeline ...

  • In Vitro Diagnostics
  • United States
  • Company
  • Demand
  • bioMerieux S.A.

Growth Hormone Function Tests - Medical Devices Pipeline Assessment, 2020

  • $ 2500
  • August 2020
  • 29 pages

Growth Hormone Function Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Growth Hormone Function Tests - Medical Devices Pipeline Assessment, 2020" provides ...

  • Drug Development
  • In Vitro Diagnostics
  • United States
  • Company
  • Roche Group

Organ Function Assays - Medical Devices Pipeline Assessment, 2020

  • $ 2500
  • August 2020
  • 56 pages

Organ Function Assays - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Organ Function Assays - Medical Devices Pipeline Assessment, 2020" provides comprehensive information ...

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics

Hemostasis Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020

  • $ 2500
  • August 2020
  • 30 pages

Hemostasis Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Hemostasis Rapid Tests & Point of Care (POC) - Medical Devices Pipeline ...

  • In Vitro Diagnostics
  • Point Of Care Testing
  • United States
  • Company
  • Helena Laboratories Corporation

TBG Diagnostics Ltd (TDL) - Product Pipeline Analysis, 2020 Update

  • $ 750
  • July 2020
  • 39 pages

Summary TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is a molecular diagnostics company that develops, manufactures and markets molecular diagnostics kits, instruments and ...

  • In Vitro Diagnostics
  • China
  • United States
  • Company
  • TBG Diagnostics Ltd

CardioGenics Inc - Product Pipeline Analysis, 2020 Update

  • $ 750
  • July 2020
  • 25 pages

Summary CardioGenics Inc (CardioGenics), a subsidiary of CardioGenics Holdings Inc is a medical device company that manufactures sensitive diagnostic test products to the in-vitro diagnostics market.The ...

  • In Vitro Diagnostics
  • Canada
  • United States
  • Litigation And Patent
  • CardioGenics Holdings Inc.

Micronics Inc - Product Pipeline Analysis, 2020 Update

  • $ 750
  • July 2020
  • 37 pages

Summary Micronics Inc (Micronics) is a medical device company that develops and markets in vitro diagnostic products.The company provides products that include aborhcard and pannat system. Its research ...

  • Diagnostics
  • In Vitro Diagnostics
  • Infectious Disease
  • United States
  • Micronics, Inc.

HiberGene Diagnostics Ltd - Product Pipeline Analysis, 2020 Update

  • $ 750
  • July 2020
  • 37 pages

Summary HiberGene Diagnostics Ltd (HiberGene Diagnostics) is a diagnostics company.It manufactures, develops and markets molecular diagnostic tests for human infectious diseases. The company’s product ...

  • Diagnostics
  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Infectious Disease
  • Hibergene Diagnostics Limited

Proteomics International Laboratories Ltd (PIQ) - Product Pipeline Analysis, 2020 Update

  • $ 750
  • July 2020
  • 36 pages

Summary Proteomics International Laboratories Ltd (Proteomics) operates as a medical technology company that discovers new biopharmaceutical drugs.The company harnesses its proprietary proteomics-based ...

  • In Vitro Diagnostics
  • Australia
  • Europe
  • Spain
  • World

Epinex Diagnostics Inc - Product Pipeline Analysis, 2020 Update

  • $ 750
  • July 2020
  • 29 pages

Summary Epinex Diagnostics Inc (Epinex Diagnostics) is a developer of rapid diagnostic test solutions. Its product portfolio includes over-the-counter test device, Epinex G1A Test system, Epinex ACR Test ...

  • Diabetes
  • In Vitro Diagnostics
  • United States
  • Litigation And Patent
  • Epinex

The Binding Site Group Ltd - Product Pipeline Analysis, 2020 Update

  • $ 750
  • July 2020
  • 27 pages

Summary The Binding Site Group Ltd (Binding Site) is a provider of clinical diagnostic tools.It researches, develops, manufactures and distributes immunodiagnostic assays. The company’s products include ...

  • In Vitro Diagnostics
  • North America
  • United States
  • World
  • Product Initiative

Cell Expansion Market by Product, Cell Type, Application, End-User And Region - Global Forecast to 2025

  • $ 4950
  • July 2020
  • 333 pages

Increasing incidence of chronic diseases, and government investments for cell-based research are set to drive the cell expansion market.’’ The global cell expansion market size is estimated to be USD ...

  • Cell Therapy
  • In Vitro Diagnostics
  • North America
  • United States
  • Demand

Emerging Microbiology Market: Innovative Technologies and Strategic Profiles of Leading Suppliers

  • $ 1500
  • July 2020
  • 155 pages

Emerging Microbiology Market: Innovative Technologies and Strategic Profiles of Leading Suppliers This 155-page report provides detailed analyses of current and emerging technologies, and their potential ...

  • In Vitro Diagnostics
  • Business Expansion & Exit
  • Company Operations
  • Demand
  • Product Initiative

Emerging Coagulation Testing Market: Innovative Technologies and Strategic Profiles of Leading Suppliers

  • $ 1500
  • July 2020
  • 124 pages

Emerging Coagulation Testing Market: Innovative Technologies and Strategic Profiles of Leading Suppliers This 124-page report provides assessments of such technologies as chromogenic substrates, monoclonal ...

  • Coagulation Diagnostic
  • Diagnostics
  • In Vitro Diagnostics
  • Business Expansion & Exit
  • Product Initiative

Diagnostics for the Real World (Europe) Ltd - Product Pipeline Analysis, 2020 Update

  • $ 750
  • June 2020
  • 27 pages

Summary Diagnostics for the Real World (Europe) Ltd (DRW Europe) is a medical device manufacturing company that designs, manufactures, develops, and markets medical implants and instruments.It develops ...

  • Diagnostics
  • HIV AIDS
  • In Vitro Diagnostics
  • Europe
  • World

Group K Diagnostics - Product Pipeline Analysis, 2020 Update

  • $ 750
  • June 2020
  • 64 pages

Summary Group K Diagnostics (GKD) is a provider of diagnostic solutions that helps in faster diagnosis and improving patient care and minimize administrative burden on physicians.The company’s flagship ...

  • Diagnostics
  • In Vitro Diagnostics
  • Infectious Disease
  • Point Of Care Testing
  • United States

Nanomix Inc - Product Pipeline Analysis, 2020 Update

  • $ 750
  • June 2020
  • 32 pages

Summary Nanomix Inc (Nanomix) is a medical device company that develops analytical detection devices for the point of care diagnostics.The company provides Nanomix system, which is an automated system ...

  • Blood Disease
  • Hospital
  • In Vitro Diagnostics
  • United States
  • Nanomix, Inc.

NanoRepro AG (NN6) - Product Pipeline Analysis, 2020 Update

  • $ 750
  • June 2020
  • 37 pages

Summary NanoRepro AG (NanoRepro) is a manufacturer of fast-diagnostics and nutritional food supplements for home and clinical use.The company offers wide range of rapid diagnostic tests products in the ...

  • In Vitro Diagnostics
  • Germany
  • Company Financials
  • Demand
  • NanoRepro AG

Siemens Healthineers AG (SHL) - Product Pipeline Analysis, 2020 Update

  • $ 750
  • June 2020
  • 278 pages

Summary Siemens Healthineers AG (Siemens Healthineers), a subsidiary of Siemens AG, is a medical technology company that designs, develops, produces and distributes diagnostic imaging systems, clinical ...

  • Biotech Diagnostics
  • Diagnostics
  • Hormone
  • Immunodiagnostics
  • In Vitro Diagnostics

DiaSorin SpA (DIA) - Product Pipeline Analysis, 2020 Update

  • $ 750
  • June 2020
  • 88 pages

Summary DiaSorin SpA (DiaSorin) is a medical diagnostics company that develops, manufactures, and markets in vitro diagnostics reagent kits and systems.The company develops reagent kits based on Enzyme ...

  • In Vitro Diagnostics
  • Infectious Disease
  • Pathology
  • United States
  • DiaSorin S.p.A.

Bio-AMD Inc - Product Pipeline Analysis, 2020 Update

  • $ 750
  • June 2020
  • 38 pages

Summary Bio-AMD Inc (Bio-AMD), formerly Flex Fuels Energy Inc, is a medical diagnostic company.The company develops point of care (POC) medical diagnostic device business. It offers bio-alternative medical ...

  • In Vitro Diagnostic Reagent
  • In Vitro Diagnostics
  • Europe
  • United Kingdom
  • Litigation And Patent

ERBA Molecular Ltd - Product Pipeline Analysis, 2020 Update

  • $ 750
  • June 2020
  • 27 pages

Summary ERBA Molecular Ltd (ERBA Molecular) formerly Lumora Ltd a subsidiary of Erba Diagnostics Mannheim GmbH, is a medical equipment company that offers innovative molecular diagnostics.The company provides ...

  • Diagnostics
  • In Vitro Diagnostics
  • World
  • Company
  • Product Initiative

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on